ADAR1 CAPITAL MANAGEMENT, LLC enters TENAX THERAPEUTICS, INC. with 3.83M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 8/24/2026ACC: 0001940272-26-000016
10% Owner
Since Aug 2026
3.83M
Baseline shares
0.00
Direct ownership
0 positions
90.17K
Derivative underlying
2 instruments
1
Security positions
3.83M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned3.83M
Total
3.83M indirect3.83M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.83M | Indirect |
| Total | 3.83M | 3.83M indirect |
Derivative Holdings2
Pre-Funded Warrant
IndirectUnderlying security
Common Stock
Underlying shares
59.07K
Shares owned
N/A
Exercise price
0.01
Expiration
—
Exercise window
—
Warrant
IndirectUnderlying security
Common Stock
Underlying shares
31.10K
Shares owned
N/A
Exercise price
4.5
Expiration
—
Exercise window
—
Total
Underlying
90.17K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Pre-Funded Warrant Indirect | Common Stock | 0.01 | — | — | 59.07K | N/A |
| Warrant Indirect | Common Stock | 4.5 | — | — | 31.10K | N/A |
| Total | 90.17K | 0.00 | ||||